Media inquiries only, please contact Andrea Hofelich via email or phone, 202-827-2078.
The National Pharmaceutical Council announced the appointment of veteran drug pricing and health policy expert John M. O’Brien, Pharm.D., MPH, as president and chief executive officer.
NPC announced that Michael L. Ryan, PharmD, Senior Vice President, Worldwide Value, Access, Pricing and Health Economics and Outcomes Research at Bristol Myers Squibb, has been elected Chair of NPC’s Board of Directors for 2020-21.
The National Pharmaceutical Council (NPC) today announced the appointment of Robert Dubois, MD, PhD, as its interim president and CEO. The NPC Board of Directors will conduct a national search for a permanent replacement for Dan Leonard, who stepped down as NPC’s president and CEO after more than 12 years of service.
NPC announced that Dan Leonard will be stepping down as president and CEO, effective September 4.
National Pharmaceutical Council and Duke-Margolis Center for Health Policy Announce New Health Policy Fellow ( )
The National Pharmaceutical Council and Duke University's Robert J. Margolis, MD, Center for Health Policy announced that Salama Freed, PhD, has been named the 2020-22 post-doctoral health policy fellow.
The National Pharmaceutical Council (NPC) and the Pharmacy Quality Alliance (PQA) announced two research grants to address barriers patients face in accessing needed medications.